The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 03, 2015

Filed:

Nov. 17, 2011
Applicants:

David Brown, Austin, TX (US);

Lance Ford, Austin, TX (US);

Angie Cheng, Austin, TX (US);

Rich Jarvis, Austin, TX (US);

Mike Byrom, Austin, TX (US);

Dmitriy Ovcharenko, Austin, TX (US);

Eric Devroe, Pflugerville, TX (US);

Kevin Kelnar, Kyle, TX (US);

Inventors:

David Brown, Austin, TX (US);

Lance Ford, Austin, TX (US);

Angie Cheng, Austin, TX (US);

Rich Jarvis, Austin, TX (US);

Mike Byrom, Austin, TX (US);

Dmitriy Ovcharenko, Austin, TX (US);

Eric Devroe, Pflugerville, TX (US);

Kevin Kelnar, Kyle, TX (US);

Assignee:

Mima Therapeutics, Inc, Austin, TX (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/11 (2006.01); C12Q 1/68 (2006.01); C12N 15/113 (2010.01);
U.S. Cl.
CPC ...
C12Q 1/68 (2013.01); C12N 15/111 (2013.01); C12N 15/113 (2013.01); C12N 2310/14 (2013.01); C12N 2310/321 (2013.01); C12N 2310/322 (2013.01); C12N 2320/12 (2013.01); C12N 2330/10 (2013.01);
Abstract

The present invention concerns methods and compositions for introducing miRNA activity or function into cells using synthetic nucleic acid molecules. Moreover, the present invention concerns methods and compositions for identifying miRNAs with specific cellular functions that are relevant to therapeutic, diagnostic, and prognostic applications wherein synthetic miRNAs and/or miRNA inhibitors are used in library screening assays.


Find Patent Forward Citations

Loading…